cardiopulmonary function
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who voluntarily participate in this clinical trial and sign an informed consent form (2) Age 18-80 years old, male and female unlimited (3) I did not participate in any clinical research within 30 days prior to enrollment.
Exclusion criteria
Exclusion criteria: (1) Symptoms or behaviors that may affect exercise ability (within 3 days prior to enrollment), including but not limited to chest tightness, breathing difficulties, dizziness, fatigue, cough, nasal congestion, runny nose, and fever; Or ingest caffeine or alcohol; (2) People with Contraindication of cardiopulmonary exercise test (3) Allergy to materials that may be used in the study; (4) Anyone who cannot follow the research protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anaerobic Threshold AT;Metabolic Equivalent,MET; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart Rate;Respiratory Rate;Peak Oxygen Uptake,VO2 peak;Ventilatory Equivalent for Oxygen,EQO2=VE/Vo2;Oxygen Pulse,O2 pulse;Carbon Dioxide Discharge,Vco2;Maximal Expiratory Ventilation,MVV;Minute Ventilation,VE;Dyspnea index;? VO 2/?WR;Partial Pressure of Oxygen in End-tidal Gas,PETo2;Partial Pressure of Carbon Dioxide in End-tidal Gas PETco2; | — |
Countries
China
Contacts
Shanghai Fourth People's Hospital, School of Medicine, Tongji University